tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Boston Scientific Corp

BSX
Add to Watchlist
43.590USD
+0.620+1.44%
Close 07-23 16:00（ET）Quotes delayed by 15 min
64.79BMarket Cap
18.13P/E TTM

Boston Scientific Corp

43.590
+0.620+1.44%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

BSX Financials

See Boston Scientific Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Boston Scientific Corp Earnings Date

Latest Release
Jul 29, 2026
EPS / Forecast
--/0.83
Revenue / Forecast
--/5.36B
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
20.07B
19.87%
EPS(YoY)
1.96
55.45%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
97.93%0.90
18.25%0.45
60.00%0.51
144.44%0.54
35.35%0.46
11.23%0.38
-7.65%0.32
22.08%0.22
61.34%0.34
294.97%0.34
--0.34
--0.18
--0.21
--0.09
--0.36
----
----
----
----
----
Revenue
11.58%5.20B
15.90%5.29B
20.34%5.07B
22.84%5.06B
20.93%4.66B
22.44%4.56B
19.34%4.21B
14.48%4.12B
13.78%3.86B
14.90%3.73B
11.26%3.53B
10.94%3.60B
12.00%3.39B
3.68%3.24B
8.12%3.17B
5.43%3.24B
9.96%3.03B
15.43%3.13B
10.27%2.93B
53.62%3.08B
Net Profit
98.96%1.34B
18.94%672.00M
60.98%755.00M
145.99%797.00M
36.16%674.00M
11.88%565.00M
-7.13%469.00M
24.14%324.00M
65.00%495.00M
304.00%505.00M
190.23%505.00M
6.10%261.00M
209.28%300.00M
56.25%125.00M
-57.04%174.00M
43.02%246.00M
-70.34%97.00M
-59.18%80.00M
339.64%405.00M
212.42%172.00M
Net Margin
78.58%25.74%
2.87%12.67%
34.06%14.91%
100.99%15.71%
12.72%14.41%
-8.93%12.32%
-22.19%11.12%
4.18%7.82%
37.99%12.79%
211.10%13.53%
--14.29%
--7.50%
--9.27%
--4.35%
--5.90%
----
----
----
----
----
Gross Margin
1.23%64.89%
3.76%65.38%
2.06%65.47%
-1.48%63.13%
1.42%64.10%
-1.17%63.01%
1.73%64.15%
-1.40%64.08%
-0.43%63.20%
1.43%63.76%
--63.06%
--64.99%
--63.47%
--62.86%
--62.60%
----
----
----
----
----
Debt to assets ratio
-11.74%24.87%
-4.00%26.19%
-4.98%27.16%
-2.13%27.88%
-2.71%28.17%
5.30%27.28%
9.36%28.59%
5.73%28.49%
5.78%28.96%
-5.86%25.91%
--26.14%
--26.94%
--27.38%
--27.52%
--26.87%
----
----
----
----
----
Income Statement
Revenue
11.58%5.20B
15.90%5.29B
20.34%5.07B
22.84%5.06B
20.93%4.66B
22.44%4.56B
19.34%4.21B
14.48%4.12B
13.78%3.86B
14.90%3.73B
11.26%3.53B
10.94%3.60B
12.00%3.39B
3.68%3.24B
8.12%3.17B
5.43%3.24B
9.96%3.03B
15.43%3.13B
10.27%2.93B
53.62%3.08B
Operating profit
3.29%974.00M
21.05%1.24B
26.75%1.19B
4.08%944.00M
18.02%943.00M
66.02%1.03B
53.17%942.00M
49.42%907.00M
35.88%799.00M
6.55%618.00M
21.30%615.00M
21.40%607.00M
20.99%588.00M
16.70%580.00M
4.75%507.00M
-17.49%500.00M
30.29%486.00M
168.65%497.00M
74.73%484.00M
1882.35%606.00M
Net Profit
98.96%1.34B
18.94%672.00M
60.98%755.00M
145.99%797.00M
36.16%674.00M
11.88%565.00M
-7.13%469.00M
24.14%324.00M
65.00%495.00M
304.00%505.00M
190.23%505.00M
6.10%261.00M
209.28%300.00M
56.25%125.00M
-57.04%174.00M
43.02%246.00M
-70.34%97.00M
-59.18%80.00M
339.64%405.00M
212.42%172.00M
Balance Sheet
Current assets
18.39%8.68B
27.08%8.79B
-8.29%8.04B
-20.80%7.12B
-10.38%7.33B
6.23%6.92B
34.70%8.76B
52.75%8.99B
43.50%8.19B
13.09%6.51B
26.44%6.50B
15.80%5.89B
12.62%5.70B
-8.82%5.76B
-17.42%5.14B
-24.79%5.08B
-16.98%5.07B
-5.63%6.32B
1.12%6.23B
16.46%6.76B
Total current liabilities
-9.63%4.57B
-15.00%5.44B
-9.85%5.33B
-6.92%5.19B
2.89%5.06B
29.72%6.40B
29.07%5.91B
22.23%5.58B
20.40%4.92B
29.71%4.93B
29.02%4.58B
17.49%4.56B
-4.49%4.08B
-11.02%3.80B
-11.76%3.55B
-4.66%3.88B
25.99%4.28B
16.11%4.27B
21.80%4.02B
31.05%4.07B
Total assets
10.49%44.35B
10.86%43.67B
12.16%42.71B
11.99%41.56B
9.47%40.14B
12.12%39.40B
11.85%38.08B
10.44%37.11B
11.48%36.67B
8.21%35.14B
6.56%34.04B
4.39%33.60B
1.72%32.89B
0.74%32.47B
0.22%31.95B
3.28%32.19B
4.65%32.34B
4.72%32.23B
3.35%31.88B
1.12%31.17B
Total liabilities
3.13%18.25B
10.40%19.20B
11.42%19.08B
14.59%18.91B
7.23%17.69B
11.44%17.39B
14.80%17.12B
9.15%16.50B
11.62%16.50B
4.77%15.61B
4.24%14.91B
1.19%15.12B
-5.25%14.78B
-4.56%14.90B
-7.19%14.31B
-1.89%14.94B
2.77%15.60B
1.01%15.61B
0.88%15.41B
0.12%15.23B
Total equity
16.30%26.10B
11.22%24.47B
12.76%23.63B
9.92%22.65B
11.30%22.45B
12.66%22.00B
9.55%20.96B
11.49%20.61B
11.37%20.17B
11.14%19.53B
8.44%19.13B
7.15%18.48B
8.21%18.11B
5.72%17.57B
7.16%17.64B
8.21%17.25B
6.46%16.73B
8.46%16.62B
5.77%16.46B
2.09%15.94B
Cash Flow Statement
Net operating income
-35.98%347.00M
-6.25%1.36B
34.03%1.34B
58.06%1.28B
230.49%542.00M
52.04%1.46B
43.35%1.00B
23.74%813.00M
-13.68%164.00M
18.44%957.00M
49.04%699.00M
113.31%657.00M
422.03%190.00M
68.68%808.00M
0.86%469.00M
-52.02%308.00M
-120.70%-59.00M
-28.83%479.00M
-27.68%465.00M
137.78%642.00M
Net investment
-18.20%-591.00M
86.18%-512.00M
64.82%-502.00M
-315.50%-1.13B
-75.44%-500.00M
-251.76%-3.70B
-624.37%-1.43B
67.74%-271.00M
41.12%-285.00M
-475.41%-1.05B
12.44%-197.00M
-2796.55%-840.00M
69.25%-484.00M
60.30%-183.00M
81.36%-225.00M
---29.00M
-2316.90%-1.57B
-213.61%-461.00M
-835.66%-1.21B
100.00%0.00
Net financing
-211.59%-260.00M
-185.98%-184.00M
-1585.71%-104.00M
-1516.67%-340.00M
-85.15%233.00M
1326.67%214.00M
-56.25%7.00M
-44.19%24.00M
2373.91%1.57B
1400.00%15.00M
108.04%16.00M
112.50%43.00M
-1050.00%-69.00M
112.50%1.00M
-3416.67%-199.00M
-17300.00%-344.00M
93.68%-6.00M
99.02%-8.00M
102.41%6.00M
-99.82%2.00M

FAQs

What is the total revenue of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its total revenue reached 20.07B, with a year-on-year change of 16.75B.

What are the current assets of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its current assets were 8.79B, with a year-on-year change of 27.08.

What are the total assets of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its total assets of Boston Scientific Corp were 43.67B, with a year-on-year change of 10.86.

What are the total liabilities of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its total liabilities of Boston Scientific Corp were 19.20B, with a year-on-year change of 10.40.

What is the total equity of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its total equity of Boston Scientific Corp was 24.47B, with a year-on-year change of 11.22.

What is the net operating income of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its net operating income of Boston Scientific Corp was 4.49B, with a year-on-year change of 22.16.

What is the net investment of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its net investment of Boston Scientific Corp was -2.64B, with a year-on-year change of 53.58.

What is the net financing of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its net financing of Boston Scientific Corp was -395.00M, with a year-on-year change of -121.78.

What is the Earnings Per Share (EPS) of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its Earnings Per Share (EPS) was 1.96, with a year-on-year change of 55.45.

What is the net income of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its net income was 2.90B, with a year-on-year change of 56.40.

What is the net margin of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its net profit margin was 14.41, with a year-on-year change of 30.70.

What is the gross margin of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its gross margin was 64.54, with a year-on-year change of 1.46.

What is the debt-to-asset ratio of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its debt-to-asset ratio was 26.19, with a year-on-year change of -4.00.

What is the Return on Equity (ROE) of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its Return on Equity (ROE) was 12.60, with a year-on-year change of 39.56.

What is the Return on Assets (ROA) of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its Return on Assets (ROA) was 6.96, with a year-on-year change of 40.56.

What is the operating profit of Boston Scientific Corp?

According to Boston Scientific Corp's FY2025 earnings report, its operating profit was 4.49B, with a year-on-year change of 22.16.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy